4//SEC Filing
MCENANY PATRICK J 4
Accession 0001161697-24-000457
CIK 0001369568other
Filed
Nov 20, 7:00 PM ET
Accepted
Nov 21, 5:11 PM ET
Size
14.7 KB
Accession
0001161697-24-000457
Insider Transaction Report
Form 4
MCENANY PATRICK J
DirectorPresident and CEO10% Owner
Transactions
- Exercise/Conversion
Common stock, par value $0.001 per share
2024-11-19$3.54/sh+98,345$348,141→ 4,576,514 total - Sale
Common stock, par value $0.001 per share
2024-11-19$21.19/sh−98,345$2,083,734→ 4,478,169 total - Sale
Common stock, par value $0.001 per share
2024-11-20$21.29/sh−72,500$1,543,525→ 4,478,169 total - Exercise/Conversion
Options to purchase common stock
2024-11-20−72,500→ 1,792,745 totalExercise: $3.54Exp: 2025-05-29→ Common Stock (72,500 underlying) - Exercise/Conversion
Common stock, par value $0.001 per share
2024-11-20$3.54/sh+72,500$256,650→ 4,550,669 total - Exercise/Conversion
Options to purchase common stock
2024-11-19−98,345→ 1,865,245 totalExercise: $3.54Exp: 2025-05-29→ Common Stock (98,345 underlying)
Footnotes (4)
- [F1]Shares were sold for personal reasons, including paying federal income taxes and diversifying the Reporting Person's portfolio. Shares were not sold as a result of any disagreement with the Company. Mr. McEnany remains the non-executive chairman of the Company's Board of Directors and the Company's largest individual, non-institutional shareholder.
- [F2]Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $21.11 to $21.31 per share.
- [F3]Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $21.05 to $21.455 per share.
- [F4]Options vested in three equal tranches on May 29, 2019, 2020 and 2021.
Documents
Issuer
CATALYST PHARMACEUTICALS, INC.
CIK 0001369568
Entity typeother
Related Parties
1- filerCIK 0000929985
Filing Metadata
- Form type
- 4
- Filed
- Nov 20, 7:00 PM ET
- Accepted
- Nov 21, 5:11 PM ET
- Size
- 14.7 KB